Utah’s dentistry board urged the state to revoke Nicholas LaFeber’s license after reports of failed root canals and poor dental work. Instead, regulators reinstated it.

Author Barbara Kingsolver opened the facility in January with royalties from her Pulitzer Prize-winning novel, “Demon Copperhead,” whose plot revolves around Appalachia’s opioid crisis.

Thermo Fisher Scientific announced an R&D partnership with AstraZeneca BioVentureHub. Crinetics received FDA approval of Palsonify (paltusotine) to treat acromegaly in adults. The agency approved ...

To read yesterday’s edition of Five things for pharma marketers to know, click here.

In its third acquisition since it started working with private equity partner Knox Lane more than two years ago, Spectrum Science has folded healthcare marketing agency Return on Focus into its ...

Much of this risk to hospitals is not captured by flood maps issued by the Federal Emergency Management Agency, which have served as the nation’s de facto tool for flood estimation for half a century, ...

Marketers of any variety need no introduction to Dove’s Real Beauty. The iconic Ogilvy campaign, launched in 2004 on behalf of the Unilever-owned brand and still running strong after more than two ...

Cosmetic surgery chains across the country are attracting patients by promising “minimally invasive” operations to reshape their bodies or get rid of stubborn fat — even helping arrange outside ...

Jessica Calef, head of OTC and pharma partnerships at Reddit, will provide the morning keynote at the 2025 MM+M Media Summit.

Holly K. Hacker and Brett Kelman and Daniel Chang, KFF Health News Much of this risk to hospitals is not captured by flood maps issued by the Federal Emergency Management Agency, which have served as ...

Pfizer strikes MFN deal with White House as part of TrumpRx launch; FDA to be “exempt” from government shutdown; Indivior has stopped marketing Opvee.

In a Truth Social post, Trump noted that the White House would place a 100% tariff on “any branded or patented” pharmaceutical product — unless a company was investing in manufacturing facilities in ...